Skip to main content

SCoV-2 Ag Detect™ Rapid Self-Test

Redefining Simple. Visual Read COVID-19 Self Test


Contact your local Chembio Representative to learn more about our Detect test.

An FDA EUA visual read rapid self-test for detection of SARS-CoV-2 Antigen in nasal swab specimens.

Performance Characteristics

  • Positive Percent Agreement (PPA) - 85.71%
  • Negative Percent Agreement (NPA) - 100%


  • Over The Counter Self-Test - Test in the privacy of your own home
  • Symptomatic and asymptomatic serial testing
  • Easy to use shallow nasal swab direct to cassette format
  • Fast results in only 20 minutes
  • Self collection for individuals 14 years and older; or with adult-collection for children as young as 2 years old


  • No appointment or prescription required
  • No waiting in lines
  • Room temperature storage
  • Test employees without additional medical licensing
  • Local Sales Representatives available for support

Test for SARS-CoV-2 in 3 Easy Steps with SCoV-2 Ag Detect™ Rapid Self-test*

Detect Self Test Instruction Diagram

Chembio has been an innovator in infectious disease testing for over 25 years with specific expertise in HIV, Syphilis, Zika, Ebola, Dengue, Chikungunya and others.

Product Information*

Information Type Product Details
Time to Results 20 minutes
Sample Minimally invasive shallow nasal swab specimen
Result Interpretation Visual Read; No instrument required
Storage Conditions Room Temperature
Method Lateral Flow

* Refer to product insert for details

Ordering Information

Product # of Tests Catalog Number
SCoV-2 Ag Detect™ Rapid Self Test 2 CAGS-2-CDS

* This test has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; This test has been authorized only for the detection ofproteins from SARSCoV-2, influenza A and influenza B, not for any other viruses or pathogens; The emergency use of this test is only authorized for the duration of the declaration thatcircumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug andCosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Powered by

Please fill out the form below and one of our sales representatives will contact you shortly.

Powered by

Please fill out the form below and our support team will contact you shortly.

Subscribe to the Chembio Mailing List